Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride

1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride is listed in the pharmaceutical impurity collection under CAS 110246-09-8. Its represented structure has formula C21H28ClN and a calculated molecular weight of 329.92 g/mol.

2D chemical structure

N H C l

Chemical identity

Catalog name
1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride
Common name
1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride
Chemical name
1-(4,4-diphenylbutan-2-yl)piperidine;hydrochloride
CAS
110246-09-8
SMILES
CC(CC(c1ccccc1)c1ccccc1)N1CCCCC1.Cl
InChI
InChI=1S/C21H27N.ClH/c1-18(22-15-9-4-10-16-22)17-21(19-11-5-2-6-12-19)20-13-7-3-8-14-20;/h2-3,5-8,11-14,18,21H,4,9-10,15-17H2,1H3;1H
InChIKey
HIPWHPBQSNWYMQ-UHFFFAOYSA-N

Record ID: Abcda654c7ee1

Computed properties

C21H28ClN Molecular formula
329.915 g/molMolecular weight
329.191 DaMonoisotopic exact mass
3.24 ŲTopological polar surface area
5.5048 Calculated LogP (Wildman–Crippen)
101.478 cm³/molMolar refractivity (Wildman–Crippen)
1 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 2 disconnected components. Calculations retain all represented components. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight329.91553.07
Calculated LogP (Wildman–Crippen)5.504892.51
Topological polar surface area3.241.30
Hydrogen-bond acceptors14.43
Hydrogen-bond donors011.28
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC21H28ClNdimensionless
Molecular weight329.915g/mol
Monoisotopic exact mass329.191Da
Topological polar surface area3.24Ų
Calculated LogP (Wildman–Crippen)5.5048dimensionless
Molar refractivity (Wildman–Crippen)101.478cm³/mol
Hydrogen-bond acceptors1count
Hydrogen-bond donors0count
Rotatable bonds (strict)5count
Heavy atoms23count
Heteroatoms2count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.4286fraction
Formal charge0e
Disconnected components2count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area146.6801Ų
Valence electrons124count
Radical electrons0count
Bertz complexity509.069index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride

Qualification and safety assessment of 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride

Explore toxicological qualification of 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride and ICH M7 mutagenic impurity assessment of 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride and acceptable intake and limit justification for 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-(1-Methyl-3,3-diphenylpropyl)piperidine Hydrochloride

Explore Altox services and software through the Altox Pharma-Hub.